Bivalirudin Injection, Powder, Lyophilized, For Suspension
Product Images NDC 70436-025

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bivalirudin (NDC 70436-025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Image 01)

Chemical structure of bivalirudin, showing the detailed molecular composition and peptide chain. The structure includes multiple amino acid residues and indicates a variable component represented as xCF3CO2H where x ranges from 1.7 to 2.6.*

FDA Label Image

Vial-label-v1.2 (Image 02)

Label for Bivalirudin for Injection 250 mg per vial, a lyophilized powder for intravenous use. The label states it is for single-dose only and instructs to discard unused portions. Manufactured by Henan Poly Pharm Co., Ltd and distributed by Slate Run Pharmaceuticals, LLC. The label includes dosage details and storage instructions, with a barcode and NDC 70436-02580.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.